drugset / Trial / NCT05560477

Study to Evaluate the Safety and Efficacy of AM3101 to Augment Meniscal Healing

NCT05560477 ↗

RandomizedParallel-groupQuadruple-blindTreatment

Summary

The purpose of this clinical trial is to assess the safety and efficacy of AM3101 to facilitate meniscal repair and reduce the incidence of non-healing complications and morbidities associated with a failed meniscal repair. This is a prospective, randomized, controlled, double-blinded, multi-center study.

Timeline

Start
2023-04-26
Primary completion
2027-01
Completion
2027-06

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject AM3101 Unknown — —

Indications

No indication recorded.